| 000 | 04557nam a22006375i 4500 | ||
|---|---|---|---|
| 001 | 978-3-030-35918-8 | ||
| 003 | DE-He213 | ||
| 005 | 20211012180217.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 200219s2020 sz | s |||| 0|eng d | ||
| 020 |
_a9783030359188 _9978-3-030-35918-8 |
||
| 024 | 7 |
_a10.1007/978-3-030-35918-8 _2doi |
|
| 050 | 4 | _aRS380 | |
| 050 | 4 | _aRS190-210 | |
| 072 | 7 |
_aTDCW _2bicssc |
|
| 072 | 7 |
_aMED072000 _2bisacsh |
|
| 072 | 7 |
_aTDC _2thema |
|
| 082 | 0 | 4 |
_a615.19 _223 |
| 245 | 1 | 0 |
_aAdvances in Pharma Business Management and Research _h[electronic resource] : _bVolume 1 / _cedited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen. |
| 250 | _a1st ed. 2020. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2020. |
|
| 300 |
_aX, 85 p. 11 illus. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aChapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. | |
| 506 | 0 | _aOpen Access | |
| 520 | _aThis open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. | ||
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 | _aHealth care management. | |
| 650 | 0 | _aHealth services administration. | |
| 650 | 0 | _aMedical laws and legislation. | |
| 650 | 0 | _aPharmacy. | |
| 650 | 0 | _aPharmacy management. | |
| 650 | 1 | 4 |
_aPharmaceutical Sciences/Technology. _0https://scigraph.springernature.com/ontologies/product-market-codes/B21010 |
| 650 | 2 | 4 |
_aHealth Care Management. _0https://scigraph.springernature.com/ontologies/product-market-codes/527030 |
| 650 | 2 | 4 |
_aMedical Law. _0https://scigraph.springernature.com/ontologies/product-market-codes/R16005 |
| 650 | 2 | 4 |
_aPharmacy. _0https://scigraph.springernature.com/ontologies/product-market-codes/F00008 |
| 650 | 2 | 4 |
_aPharmacoeconomics and Health Outcomes. _0https://scigraph.springernature.com/ontologies/product-market-codes/H69020 |
| 700 | 1 |
_aSchweizer, Lars. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aDingermann, Theodor. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aRusse, Otto Quintus. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aJansen, Christian. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030359171 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030359195 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030359201 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-030-35918-8 |
| 912 | _aZDB-2-SBL | ||
| 912 | _aZDB-2-SXB | ||
| 912 | _aZDB-2-SOB | ||
| 950 | _aBiomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | _aBiomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 999 |
_c552181 _d552116 |
||